Tiziana Life Sciences Announces Study Results from Intranasa

19.04.2024 - - Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a platform session at the Annual Meeting of the American ... Seite 1

Related Keywords

Tarun Singhal , John Corboy , University Of Colorado Anschutz Medical Campus , Mountain Multiple Sclerosis Center , Imaging Program In Neurologic Diseases At Brigham , Professor Of Neurology At Harvard Medical School , Neurologic Diseases , Mass General Brigham Healthcare , Associate Professor , Harvard Medical School , Rocky Mountain Multiple Sclerosis Center , Colorado Anschutz Medical , Tiziana Life Sciences Chart , Iziana Life Sciences Kurs , Iziana Life Sciences Aktie ,